Protalix BioTherapeutics (PLX) Reports Q3 Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.56 -0.03 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.59 | 52 Week High | $1.11 | |||
| Open | $2.60 | 52 Week Low | $0.41 | |||
| Day High | $2.62 | P/E | N/A | |||
| Day Low | $2.54 | EPS | $-0.29 | |||
| Volume | 726,275 | |||||
